Skip To Main Content

Transplantační medicína

Nejnovější trendy

Prozkoumejte nejčtenější články a videa na Campus Sanofi

Seřadit
Video instructivo - Registro en aplicación EDL Diagnóstico

Video instructivo - Registro en aplicación EDL Diagnóstico

Consulte el siguiente video instructivo para registrarse desde la aplicación EDL Diagnóstico. ¡Disponible para PC y dispositivos móviles!

GUIDE FOR HEALTH CARE PROFESSIONALS

Valproate Risk Minimization Material - Guide for Health Care Professionals

PATIENT CARD FOR VALPROATE: CONTRACEPTION AND PREGNANCY

Valproate Risk Minimization Material - Patient Card

PATIENT GUIDE

Valproate Risk Minimization Material - Patient Guide

Dự Phòng Thuyên Tắc Huyết Khối Tĩnh Mạch Trên Bệnh Nhân Chấn Thương Nặng, Đa Chấn Thương Theo Hướng Dẫn Điều Trị Của Bộ Y Tế 2023

Dự Phòng Thuyên Tắc Huyết Khối Tĩnh Mạch Trên Bệnh Nhân Chấn Thương Nặng, Đa Chấn Thương Theo Hướng Dẫn Điều Trị Của Bộ Y Tế 2023

BR1DGE Symposium at EASD 2024

BR1DGE Symposium at EASD 2024

At the BR1DGE symposium at EASD 2024, leading experts shared new insights on early-stage (Stage 1 and 2) autoimmune type 1 diabetes (T1D), emphasizing the importance of screening for islet antibodies (IAbs) together with monitoring and education. Early type 1 diabetes identification can help to prepare people for a life with T1D.

This article is intended to be a summary only. Additional topics were covered in the live symposium in line with the applicable regulations but are not included on the BR1DGE platform.

Impacto de Rinitis Alérgica y Urticaria en Calidad de Vida

Impacto de Rinitis Alérgica y Urticaria en Calidad de Vida

Advances in the biology of chronic GVHD

Advances in the biology of chronic GVHD

Updated European Society of Blood and Marrow Transplantation consensus recommendations for GVHD prophylaxis and management in hematological malignancies after stem-cell transplantation

Updated European Society of Blood and Marrow Transplantation consensus recommendations for GVHD prophylaxis and management in hematological malignancies after stem-cell transplantation

Clinical outcomes of cGvHD following allogeneic HSCT: A Swedish population-based real-world registry study

Clinical outcomes of cGvHD following allogeneic HSCT: A Swedish population-based real-world registry study

Clinical outcomes of cGvHD following allogeneic HSCT: A Swedish population-based real-world registry study

Clinical outcomes of cGvHD following allogeneic HSCT: A Swedish population-based real-world registry study

Updated European Society of Blood and Marrow Transplantation consensus recommendations for GVHD prophylaxis and management in hematological malignancies after stem-cell transplantation

Updated European Society of Blood and Marrow Transplantation consensus recommendations for GVHD prophylaxis and management in hematological malignancies after stem-cell transplantation